Survival advantage for exemestane observed in phase III breast cancer trial reported at ASCO meeting May 28, 1999
NCI scientists on track to develop a vaccine to prevent, treat genital warts and cervical cancer May 28, 1999
LED proceeds to phase II trials in prostate cancer due to acceptable toxicity, evidence of efficacy May 27, 1999
RSS